cardectomy was not performed. Though both patients had toxic confusional states for several weeks postoperatively there was distinct symptomatic and objective evidence of improvement which has been maintained for over 16 months. Previous reports of surgical treatment of 22 patients without eosinophilia (all of whom had endomyocardial resection) and three other patients with eosinophilia have shown equally encouraging results. There has been no evidence of recurrence or progression of heart damage in follow-up periods of up to seven years. It is concluded that cardiac surgery is an important advance in the treatment of endomyocardial disease in patients with or without an eosinophilia.
Cardiac surgery for endomyocardial fibrosis was introduced by Gerbaux et al. l The procedure involved removal of the fibrotic and thrombotic endocardial tissues, with replacement or repair of involved mitral and/or tricuspid valves. It was shown to be safe and effective2 and there are now reports of over 22 patients treated in this way. Surgery is now generally accepted as an im,portant advance in the management of this condition.
In 1973 it was also recognised that Loffler's endomyocardial disease and tropical endomyocardial fibrosis were pathologically indistinguishable4 which supported earlier suggestions that they had a similar pathogenesis, reviewed by Olsen and Spry.5 The term eosinophilic endomyocardial disease is now applied to both. 6 The management of endomyocardial disease in patients with eosinophilia was, however, complicated by the problem that heart disease was part of a systemic disorder in which many different organs might become involved -the hypereosinophilic syndromes. Initial results of cardiac surgery in three patients, including one who had a successful mitral Received for publication 16 February 1981 valve repair in 1973,7 were promising, 8 
Operative findings
Dense white fibrous tissue covered the inflow tract and body of the right ventricle, affecting both chordae and papillary muscles of the tricuspid valve, which was contained in a dilated ring. A strip of fibrous tissue was dissected from the inner wall of the right ventricle (Fig. 3) . The papillary muscles were divided and the tricuspid valve was replaced with a 35 mm internal diameter Carpentier Edwards xenograft. In the left ventricle the only visible lesion was a small area of fibrosis attached to the inferolateral half of the posterior mitral valve cusp, producing regurgitation. The mitral valve was replaced with a 33 mm internal diameter Carpentier Edwards xenograft.
Pathology Macroscopy: The strip of thick fibrous endocardium from the right ventricle in which a papillary muscle was also embedded was 70 x 38 mm in size and measured up to 6 mm in thickness.
The tricuspid valve was opaque and uniformly thickened but showed no obvious involvement by fibrotic process of endomyocardial disease.
The anterior leaflet of the mitral valve was not involved and showed minimal thickening of the clear zone and focal thickening of chordae, whereas the posterior leaflet was considerably thickened and matting of the chordae was seen.
Histology: In the thickened endocardium the typical arrangement into three zones was noted, consisting of loosely arranged connective tissue superficially, followed by dense collagen tissue. The lowest zone, closest to the myocardium, "the granulation tissue layer", contained dilated vessels and a sparse chronic inflammatory infiltrate, consisting predominantly of lymphocytes.
The tricuspid valve showed uniform, non-specific thickening but along the line of closure vascular fibrotic tissue was present, resembling the granulation tissue layer. The posterior leaflet was involved by zonally arranged fibrosis which extended along the chordae tendineae and the basal zone (that is where the leaflet takes origin from its valve ring). 
A previously healthy 24-year-old man presented with a few weeks' history of heart failure, his deteriorating exercise tolerance eventually preventing him from walking short distances on the flat. On examination he looked ill and jaundiced with gross right heart failure. Signs of restrictive cardiomyopathy included a tachycardia at rest of 150/minute, a raised jugular venous pressure which rose higher on inspiration, and biventricular hypertrophy. There were murmurs of mitral and tricuspid regurgitation and a gallop rhythm. There was an eosinophilia of 5.1 x 109/1, with mature but vacuolated and degranulated eosinophils in blood films as described in case 1. Despite a wide range of investigations for allergic or parasitic causes, no cause for the eosinophilia was found though the serum IgE was increased to 2840 IU/ml. He was considered to have severe endomyocardial disease with predominant mitral valve involvement caused by the hypereosinophilic syndrome in a quiescent phase.
Preoperative cardiac investigations
There was slight cardiomegaly and pulmonary oedema in chest radiographs, and electrocardiograms showed sinus rhythm, right axis deviation, and right ventricular hypertrophy. On ambulatory Holter monitoring, frequent multifocal extrasystoles were seen with one episode of supraventricular tachycardia. Cardiac pressure studies are shown in Table 1 . A right ventricular angiogram showed an enlarged right ventricle and obliteration of the apex with mild tricuspid regurgitation (Fig. 4) . A left ventricular angiogram showed severe mitral regurgitation with a hyperdynamic left ventricle (Fig. 5) . The left ventricular cavity was of normal size but the wall and apex had some irregularities. Though Postoperative findings Three months after the operation he felt well. His mental state was normal and he was now able to manage two ffights of stairs without dyspnoea. He no longer required treatment with diuretics. The eosinophilia persisted unchanged. Cardiac catheterisation four months after operation showed no progression of endomyocardial disease (Fig. 4 and 5 ) and the mitral valve prosthesis was functioning normally (Fig. 5) . Nine months after operation he was able to bicycle to work without becoming breathless. The only abnormal physical sign was a raised jugular venous pressure of 6 cm. Ambulatory Holter monitoring at this stage showed only a few ventricular extrasystoles and he has remained well 16 months after operation. Discussion These cases confirm that tricuspid and/or mitral valve surgery for endomyocardial disease can be successful even in patients with the hypereosinophilic syndromes, and suggest that ventricular endocardectomy may be safely carried out without risk of thrombi, emboli, or recurrence at the operative sites. The results should encourage the use of cardiac surgery in patients with severe heart failure caused by endomyocardial disease irrespective of whether they have hypereosinophilia.
Preoperative cardiac assessment was done to determine the relative importance of restriction of filling of each ventricle by endomyocardial fibrosis, obliteration with clot and/or fibrous tissue, and involvement of the mitral or tricuspid valves as in other patients with endomyocardial disease without eosinophilia in the past. The possibility was considered that the heart failure might be responsive to steroids, which have improved cardiac function in a small number of patients with hypereosinophilia and acute myocarditis.12 In both patients, however, there were clear structural reasons why surgery should be carried out and the lesions were seen clearly at operation: obliteration of the right ventricle in case 1 and severe mitral regurgitation in case 2. In the latter, operation had to be carried out urgently because of the presentation of severe heart failure; in the former, two courses of treatment with steroids had been given during the preceding four years. The effects of steroids and cytotoxic drugs on relapses in patients with hypereosinophilic syndromes have been reviewed by Parrillo et al.'0 It is not known, however, group.bmj.com on June 24, 2017 -Published by http://heart.bmj.com/ Downloaded from whether these influence the extent or progression of endomyocardial disease in such patients. Most of them are given anticoagulants throughout the course of their illness, as emboli and thrombotic complications are common. '3 In patients who present with hypereosinophilic syndromes without cardiac involvement monitoring of the number of degranulated blood eosinophils has proved to be a useful method of predicting the onset of cardiac complications. '3 The types of operation which have been carried out previously in 26 patients with endomyocardial disease, with and without an eosinophilia, are shown in Table 2 There have been few postoperative complications of surgery in patients with endomyocardial disease apart from reports that endocardectomy of the right ventricle may produce complete atrioventricular block requiring pacing. 1 16 Both of our patients had hypereosinophilia and developed a severe organic toxic confusional state soon after operation. Despite extensive neurological investigation, including lumbar puncture, brain scan, and computerised axial tomography, no cause was found. The confusion, however, resolved spontaneously within five weeks of operation, leaving no residual neurological or psychological deficit. As there were no special features in the operative procedure or the events surrounding it, it seems possible that the hypereosinophilia itself was in some way involved.
The morphological recognition of eosinophilic endomyocardial disease is well established4 5 and the zonal layering of the thick endocardium is highly characteristic. The striking feature is the extensive thickening of the endocardium which in the normal right ventricle does not exceed 10 ,um. In case 1 it measured as much as 6 mm in thickness. The disease 
